Corey Goodman, venBio
February 12, 2020 10:02 AM EST
Financing
Startups
R&D

Corey Good­man mar­shals $105M mega-round for his CD47 up­start, look­ing to break new ground in PhII

John Carroll

Editor & Founder

Corey Good­man has put an­oth­er notch on his ven­ture belt, ring­ing up a $105 mil­lion mega-round for his CD47 start­up ALX On­col­o­gy.

Fu­el­ing a start­up …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times